Shares of Transcat, Inc. (NASDAQ:TRNS – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $127.25.
Several analysts recently commented on TRNS shares. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. Northland Securities cut their price objective on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a report on Wednesday, October 30th. HC Wainwright reaffirmed a “buy” rating and issued a $156.00 price objective on shares of Transcat in a report on Tuesday, October 29th. Craig Hallum cut their price objective on Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a report on Wednesday, October 30th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $130.00 price objective (down previously from $155.00) on shares of Transcat in a report on Wednesday, October 30th.
Read Our Latest Stock Analysis on Transcat
Institutional Trading of Transcat
Transcat Trading Down 4.3 %
Transcat stock opened at $103.42 on Thursday. The firm has a market cap of $951.46 million, a price-to-earnings ratio of 52.23 and a beta of 0.69. The stock has a fifty day simple moving average of $118.26 and a two-hundred day simple moving average of $121.73. Transcat has a 12 month low of $89.39 and a 12 month high of $147.12.
Transcat (NASDAQ:TRNS – Get Free Report) last posted its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). The business had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.41 EPS. On average, equities research analysts forecast that Transcat will post 1.76 EPS for the current fiscal year.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Read More
- Five stocks we like better than Transcat
- Top Stocks Investing in 5G Technology
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Bank Stocks – Best Bank Stocks to Invest In
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Compound Interest and Why It Matters When Investing
- Time to Load Up on Home Builders?
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.